Intrexon reported $-19309000 in Pre-Tax Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Agenus AGEN:US $ -50.6M 17M
Amgen AMGN:US $ 2727M 56M
Anika Therapeutics ANIK:US $ -3.71M 5.46M
Arrowhead Research ARWR:US $ 44.37M 107.24M
Bluebird Bio BLUE:US $ -122.15M 10.09M
Bristol Myers Squibb BMY:US $ 5386M 595M
Chemocentryx CCXI:US $ -38.61M 1.92M
Heron Therapeutics HRTX:US $ -63.89M 9.24M
Immunogen IMGN:US $ -24.14M 13.03M
Intrexon XON:US $ -19.31M 5.71M
Karyopharm Therapeutics KPTI:US $ -41269000 79.87M
Macrogenics MGNX:US $ -66.44M 8.42M
Mannkind MNKD:US $ -26M 2.06M
Merk MRK:US $ 6309M 1525M
Novartis NOVN:VX SF 3912M 230M
Peregrine Pharmaceuticals PPHM:US $ 0.59M 1.66M
Rigel Pharmaceuticals RIGL:US $ -27.44M 4.74M
Sangamo Biosciences SGMO:US $ -43.92M 6.36M
Thermo Fisher Scientific TMO:US $ 3355M 760M
Veracyte VCYT:US $ -14.46M 3.15M
Xencor XNCR:US $ 23.59M 49.47M
YTE INCY:US $ 172.84M 1.75M
Ziopharm Oncology ZIOP:US $ -9.79M 2M